Design, synthesis and antitumor activity evaluation of pyrimidine derivatives containing 4-hydroxypiperidine group

被引:1
作者
Chi, Lingling [1 ,2 ]
Wang, Hao [1 ,2 ]
Yu, Fuqiang [1 ,2 ]
Gao, Chao [1 ,2 ]
Dai, Honglin [1 ,2 ]
Liu, Limin [1 ,2 ]
Wang, Zhengjie [1 ,2 ]
Dong, Yuze [2 ,3 ]
Liu, Hongmin [1 ,2 ,3 ,4 ,5 ]
Zhang, Qiurong [1 ,2 ,3 ,4 ,5 ]
机构
[1] Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou 450001, Peoples R China
[2] Inst Drug Discovery & Dev, Zhengzhou 450001, Peoples R China
[3] Ctr Drug Safety Evaluat & Res, Zhengzhou 450001, Peoples R China
[4] State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou 450052, Peoples R China
[5] Minist Educ, Key Lab Adv Drug Preparat Technol, Zhengzhou 450001, Peoples R China
基金
中国国家自然科学基金;
关键词
Pyrimidine; 4-hydroxypiperidine group; Antiproliferation; Cell cycle; Cell apoptosis; STRUCTURE-GUIDED DEVELOPMENT; BIOLOGICAL EVALUATION; MOLECULAR DOCKING; SURGICAL EXCISION; POTENT; APOPTOSIS; INHIBITOR; BIOPSY;
D O I
10.1007/s00044-023-03076-0
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In the current study, a series of pyrimidine derivatives containing the 4-hydroxypiperidine group were designed and synthesized, and the antiproliferative activity of these compounds against four human tumor cell lines (MGC-803, PC-3, A549, H1975) was evaluated by MTT method in vitro. Most of the compounds have moderate anti-proliferative activities, among which compound 17i displayed the most excellent anti-proliferative activity, with IC50 value of 3.89 +/- 0.57 mu M against H1975 cell. Preliminary antitumor mechanism studies revealed that compound 17i could inhibit colony formation and cell migration of H1975 cells. Furthermore, compound 17i induced H1975 cells apoptosis in a dose-dependent manner and H1975 cell cycle arrest in S phase to inhibit cell proliferation. These results indicates that compound 17i could be a promising lead for further studies. [GRAPHICS] .
引用
收藏
页码:2125 / 2137
页数:13
相关论文
共 43 条
  • [1] Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives bearing 1,3-thiazole moiety as novel anti-inflammatory EGFR inhibitors with cardiac safety profile
    Abdel-Aziz, Salah A.
    Taher, Ehab S.
    Lan, Ping
    Asaad, Gihan F.
    Gomaa, Hesham A. M.
    El-Koussi, Nawal A.
    Youssif, Bahaa G. M.
    [J]. BIOORGANIC CHEMISTRY, 2021, 111
  • [2] Design, Synthesis, Molecular Modeling and Antitumor Evaluation of Novel Indolyl-Pyrimidine Derivatives with EGFR Inhibitory Activity
    Ahmed, Naglaa M.
    Youns, Mahmoud M.
    Soltan, Moustafa K.
    Said, Ahmed M.
    [J]. MOLECULES, 2021, 26 (07):
  • [3] Novel Aryl-Substituted Pyrimidones as Inhibitors of 3-Mercaptopyruvate Sulfurtransferase with Antiproliferative Efficacy in Colon Cancer
    Bantzi, Marina
    Augsburger, Fiona
    Loup, Jeremie
    Berset, Yan
    Vasilakaki, Sofia
    Myrianthopoulos, Vassilios
    Mikros, Emmanuel
    Szabo, Csaba
    Bochet, Christian G.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (09) : 6221 - 6240
  • [4] Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma
    Barbaraci, Carla
    Giurdanella, Giovanni
    Leotta, Claudia Giovanna
    Longo, Anna
    Amata, Emanuele
    Dichiara, Maria
    Pasquinucci, Lorella
    Turnaturi, Rita
    Prezzavento, Orazio
    Cacciatore, Ivana
    Zuccarello, Elisa
    Lupo, Gabriella
    Pitari, Giovanni Mario
    Anfuso, Carmelina Daniela
    Marrazzo, Agostino
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (18) : 13622 - 13632
  • [5] (R)-2-Phenylpyrrolidine Substituted Imidazopyridazines: A New Class of Potent and Selective Pan-IRK Inhibitors
    Choi, Ha-Soon
    Rucker, Paul V.
    Wang, Zhicheng
    Fan, Yi
    Albaugh, Pamela
    Chopiuk, Greg
    Gessier, Francois
    Sun, Fangxian
    Adrian, Francisco
    Liu, Guoxun
    Hood, Tami
    Li, Nanxin
    Jia, Yong
    Che, Jianwei
    McCormack, Susan
    Li, Allen
    Li, Jie
    Steffy, Auzon
    Culazzo, AnneMarie
    Tompkins, Celine
    Van Phung
    Kreusch, Andreas
    Lu, Min
    Hu, Bin
    Chaudhary, Apurva
    Prashad, Mahavir
    Tuntland, Tove
    Liu, Bo
    Harris, Jennifer
    Seidel, H. Martin
    Loren, Jon
    Molteni, Valentina
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (05): : 562 - 567
  • [6] Design, synthesis and anti-tumor activity evaluation of 4,6,7-substitute quinazoline derivatives
    Dai, Honglin
    Si, Xiaojie
    Wang, Hao
    Chi, Lingling
    Gao, Chao
    Wang, Zhengjie
    Liu, Limin
    Qian, Zhuo
    Ke, Yu
    Zhang, Qiurong
    Liu, Hongmin
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2022, 31 (08) : 1351 - 1368
  • [7] Non-nucleoside structured compounds with antiviral activitydpast 10 years (2010e2020)
    Denel-Bobrowska, Marta
    Olejniczak, Agnieszka B. B.
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 231
  • [8] Design, synthesis and antibacterial activity of novel pleuromutilin derivatives with thieno[2,3-d]pyrimidine substitution
    Ding, Rongcai
    Wang, Xiaoxia
    Fu, Jianfang
    Chang, Yaoyao
    Li, Yingxue
    Liu, Yajing
    Liu, Yue
    Ma, Jinlong
    Hu, Jinxing
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 237
  • [9] Synthesis, Molecular Docking, Molecular Dynamics Studies, and Biological Evaluation of 4H-Chromone-1,2,3,4-tetrahydropyrimidine-5-carboxylate Derivatives as Potential Antileukemic Agents
    Dolatkhah, Zahra
    Javanshir, Shahrzad
    Sadr, Ahmad Shahir
    Hosseini, Jaber
    Sardari, Soroush
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2017, 57 (06) : 1246 - 1257
  • [10] Design, synthesis and anticancer evaluation of thieno[2,3-d]pyrimidine derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers
    Elmetwally, Souad A.
    Saied, Khaled F.
    Eissd, Ibrahim H.
    Elkaeed, Eslam B.
    [J]. BIOORGANIC CHEMISTRY, 2019, 88